Four Nepalese eyesight institutions share $1.3m prize

Four Nepalese institutions are sharing a €1-million ($1.3 million) prize from a Portuguese foundation for their work fighting eyesight disorders and blindness in their country.

The Lisbon-based Champalimaud Foundation's annual Vision Award, created in 2007, claims to be the biggest monetary award for work on and one of the world's largest scientific prizes.

The foundation said in a statement the winning institutions have over the past 20 years helped to reduce treatable and avoidable blindness in Nepal where, it said, such as are a major health concern.

The Tilganga Institute of Ophthalmology, Nepal Netra Jyoti Sangh, the Eastern Regional Eye Care Program involving the Sagarmatha Choudhary and Biratnagar eye hospitals, and the Lumbini Eye Institute were named as winners Wednesday.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Portuguese award goes to Helen Keller nonprofit

Sep 05, 2009

(AP) -- The Helen Keller International nonprofit organization has won a $1.4 million prize from a Portuguese foundation for its work in preventing blindness in the developing world, the foundation said Friday.

Top Portuguese award goes to 2 US scientists

Jun 11, 2010

(AP) -- Two U.S. scientists have won a $1.3 million (euro1.07 million) award for their work in understanding how humans see, a Portuguese scientific foundation said Friday.

Open-angle glaucoma up 22 percent in last 10 years

Jan 01, 2013

(HealthDay)—The prevalence of open-angle glaucoma has increased more than 20 percent in the last 10 years and currently affects more than 2.7 million Americans age 40 years and older, according to a report ...

Recommended for you

Vitamin D link to short-sightedness ruled out

11 hours ago

New findings from the Children of the 90s study at the University of Bristol suggest that children with low levels of vitamin D in their blood are not at increased risk of developing myopia (short-sightedness).

Multidose eye drop approach approved by joint commission

Dec 14, 2014

(HealthDay)—A policy and procedural approach to the use of multidose eye drops has been approved by The Joint Commission and can reduce costs for patients and facilities, according to an article published ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.